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center and hypoechoic peripheral rim are the diagnostic
ultrasonic features. Hepatic capsular retractions due to
extensive fibrosis can be identified by CT and MRI. The
lesions are usually hypointense on T1-weighted images
and hyperintense on T2-weighted images. There is no
consensus on treatment of hepatic epithelioid heman-
gioendothelioma, which ranges from hepatic resection,
hepatectomy, liver transplantation, chemo- and radio-
therapy, and thermoablation. This case report presents a
36-year-old female, incidentally diagnosed to have he-
patic epithelioid hemangioendothelioma, which was
treated by right hepatectomy and was attended by
favorable outcome.
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Epithelioid hemangioendothelioma is an angiocentric
vascular neoplasm of soft tissue, characterized by prolifera-
tion of endothelial cells with an epithelioid morphology.1
The biologic behavior of the tumor has been described
as “borderline” in terms of malignant potential and
recurrence2 but this still remains an area of debate.3
Epithelioid hemangioendothelioma can involve lung and
mediastinum,4 thyroid,5 peritoneum,6 lymph nodes,7 bone,8
palate9 and liver.10 We report a case of asymptomatic
primary hepatic epithelioid hemangioendothelioma (HEH)his is an open access article under the CC BY-NC-ND license
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D. Redaelli and S.S. Guraya244which was incidentally diagnosed by routine abdominal
imaging and managed successfully by hepatic resection.Figure 2: T2 fat sat image shows “target” like appearance with
high signal intensity and the more hyperintense central region of
the nodule.Case report
A 36-year-old Caucasian lady underwent routine ul-
trasound of abdomen and was found to have a focal lesion
in the 8th hepatic segment measuring 4 cm in diameter.
The lesion had “target” appearance due to hyperechoic
center and hypoechoic peripheral rim. Her abdominal ex-
amination and liver function tests were unremarkable. For
better characterization of the lesion, an MRI on 1.5 T
(Philips Achieva) was performed as shown in Figures 1e4.
There is a hypointense lesion in the right lobe of liver with
lower signal intensity in the center on T1-weighted images
(Figure 1), while T2 fat sat image (Figure 2) is showing
“target” like appearance with high signal intensity and a
hyperintense central region of the nodule. While the
dynamic contrast-enhanced phase (Figure 3(a)e(c))
showing slight enhancement at the periphery with
gradual and delayed central enhancement of the lesion.
Hepatobiliary phase (Figure 4) is showing a peripheral
rim of hypointensity with a hyperintense central region
most probably due to prolonged retention of contrast
material MULTIHANCE (gadobenate dimeglumine) in
it. Percutaneous Fine Needle Aspiration Cytology
(FNAC) could not contribute to the diagnosis and was
indecisive. Two months after first ultrasound scan,
patient underwent right hepatectomy, cholecystectomy
and excision of one lymph node from porta hepatis.
Histological diagnosis reported a primary hepatic
epithelioid hemangioendothelioma with no malignant
transformation. No lymph nodes were involved by the
tumor. Figure 5(a)e(c) demonstrate postoperative
contrast-enhanced CT and MRI with no residual or
recurrent lesions. The patient is being followed up by 6-
month abdominal CT and remained well during the one-
year follow-up.Figure 1: The lesion is hypointense with lower signal intensity in
the center on T1-weighted images.Discussion
Primary HEHs are extremely uncommon, with a reported
incidence of one per million population.11 There is 3:2
preponderance in favor of females12 and the disease occurs
most often in adults, with a mean age of 41.7 years (age
range; 30e40 years).13 Our 36-year-old female patient also
matches the published demographic findings. There are no
clear risk factors for the development of HEH, although oral
contraceptives,14 vinyl chloride,15 asbestos,16 thorotrast,17
major hepatic trauma,18 and alcohol consumption19 are
known to be contributory agents in HEH pathogenesis. We
could not find any risk factor in our patient.
The rate of missing the tumor has been reported to be as
high as 60e80%.20 The most common misdiagnoses were
cholangiocarcinoma, angiosarcoma, hepatocellular
carcinoma, metastatic hepatic carcinoma, and sclerosing
hemangioma.13 Mixed hamartoma, bile duct adenoma,
cirrhosis, venoocclusive disease, fibrolamellar carcinoma,
postnecrotic fibrosis, and BuddeChiari syndrome were less
common misdiagnoses.21
Presentation of the disease is essentially nonspecific and
the patients can have weight loss and right upper quadrant
pain. In rare cases, jaundice and hepatic dysfunction may be
noted due to replacement of liver parenchyma by the tu-
mor.22 Tumor markers (N-fetoprotein, carcinoembryonic
antigen, CA 19-9) remain normal in cases of HEH.
Two striking histological features of HEH are described
in literature; the presence of characteristic dendritic and/or
epithelioid cells with evidence of vascular differentiation and
intracytoplasmic lumina containing red blood cells; and
abnormal stroma, which varies from myxomatous to densely
fibrotic.23 The definitive diagnosis of malignant vascular
tumors requires immunohistochemical evidence of
endothelial differentiation. Immunohistochemical reactivity
for FVIII-RAg, CD31, CD34, and cytokeratins has been
demonstrated in endothelial cells.24 Although histology is the
prerequisite for a correct diagnosis, it is of little value in
predicting outcome.25
MRI depicts multiple hypoattenuating masses, which
coalesce in the periphery of the liver to form large confluent
regions. Focal capsular retraction is usually reported.26
Figure 3: (a), (b), and (c): On dynamic three phases (with no
contrast/ venous 70 sec / and late phase 3 min) contrast-enhanced
image, there is a slight enhancement in the periphery of the lesion
with gradual and delayed central enhancement.
Figure 4: The hepatobiliary phase image shows a peripheral rim of
hypointensity with an hyperintense central region most probably
due to prolonged retention of contrast material in it.
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invasion, hepatic vein narrowing or obliteration, inferior
vena cava compression, and collateral vessels. HEH is
usually hypointense on T1-weighted images andhyperintense on T2-weighted images and the target appear-
ance of the lesions may be influenced by a central sclerotic
area and a peripheral zone of cellular proliferation.27
Radiologically, two distinct types of HEH with different
stages have been described: the nodular type in the early
stage of HEH; and the diffuse type, in advanced disease due
to an increase in size and coalescence of the lesions often
associated with hepatic vascular invasion.28 HEH may
appear as discrete nodules (0.5e12 cm) or as complex,
confluent masses.27 Many lesions are peripheral and invade
the liver capsule. Flattening or retraction of the liver
capsule because of fibrosis and compensatory hypertrophy
of the unaffected liver segments may be diagnostic clues.29
Ultrasonography may delineate either discrete nodules or
diffuse echotexture regions with extensive hepatic paren-
chymal distortion.27 CT scan complements MRI and
ultrasound findings. Because, on contrast-enhanced scans,
tumor nodules may become isodense to liver parenchyma,
the extent of involvement may be defined better on unen-
hanced images.
There is no agreed treatment strategy for HEH owing to
its rarity, heterogeneous status, and variable clinical
outcome. The management modalities for patients with liver
malignancies include surgical resections, liver trans-
plantation,6 tumor embolization, chemotherapy and
radiotherapy,30 thermoablation, percutaneous ethanol
injection, and even follow-up without any therapy.31 In a
study of 286 HEH patients, 71 were not given any
treatment and the reported mortality was more than 50%.
Hence, a “no treatment” or “wait and see” strategy is not
feasible.12 Liver transplantation is an accepted treatment
option for HEH and is associated with excellent
outcomes.6 The selection of surgical therapy depends on
extent of liver involvement, bi or uni lobar, multifocality,
and extrahepatic extensions. Our patient had right
hepatectomy as the disease was localized in the right lobe
without extrahepatic extension. The decision on a
treatment strategy for HEH has to be tailored to each
patient, the rate of disease progression, and the response to
other treatment modalities may be important determinants
for decision making. For primary HEH, Yokoyama et al.
Figure 5: (a), (b), and (c) represent CT arterial phase, CT portal
venous phase, and contrast-enhanced MRI T1 sequence (Portal
Venous phase), respectively.
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73%, and 48%, respectively.32 Pichlmayr et al. published a
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